T.MAN Pharmaceutical PCL (BKK:TMAN) Total Liabilities: ฿1,635 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:TMAN T.MAN Pharmaceutical PCL BKK:TMAN
21 GF Score
Price ฿11.30
! 2 Warning Signs
View Full Analysis

What is T.MAN Pharmaceutical PCL Total Liabilities?

T.MAN Pharmaceutical PCL BKK:TMAN -0.88% 21 Total Liabilities is ฿1,635 Mil as of Mar. 2026. GuruFocus rates BKK:TMAN with a GF Score™ of 21/100. The stock has 2 warning signs investors should review.

T.MAN Pharmaceutical PCL's Total Liabilities for the quarter that ended in Mar. 2026 was ฿1,635 Mil.

T.MAN Pharmaceutical PCL's quarterly Total Liabilities declined from Sep. 2025 (฿1,827.54 Mil) to Dec. 2025 (฿1,666.72 Mil) and declined from Dec. 2025 (฿1,666.72 Mil) to Mar. 2026 (฿1,635.20 Mil).

T.MAN Pharmaceutical PCL's annual Total Liabilities increased from Dec. 2023 (฿1,107.85 Mil) to Dec. 2024 (฿1,685.72 Mil) but then declined from Dec. 2024 (฿1,685.72 Mil) to Dec. 2025 (฿1,666.72 Mil).

T.MAN Pharmaceutical PCL Total Liabilities Historical Data

* Premium members only.

The historical data trend for T.MAN Pharmaceutical PCL's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

T.MAN Pharmaceutical PCL Total Liabilities Chart

T.MAN Pharmaceutical PCL Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Total Liabilities
1,235.59 1,107.85 1,685.72 1,666.72

T.MAN Pharmaceutical PCL Quarterly Data
Dec22 Jun23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,620.78 1,530.71 1,827.54 1,666.72 1,635.20
BKK:TMAN
21GF Score
T.MAN Pharmaceutical PCL BKK:TMAN
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

T.MAN Pharmaceutical PCL Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

T.MAN Pharmaceutical PCL's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1553.304+(63.284+1.1039999999998
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+49.024+0)
=1,667

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=3783.717-2117.001
=1,667

T.MAN Pharmaceutical PCL's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1519.329+(64.341+1.1780000000001
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+50.354+0)
=1,635

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=3866.834-2231.632
=1,635

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of ฿1,635 Mil mean?
T.MAN Pharmaceutical PCL (BKK:TMAN) has a Total Liabilities of ฿1,635 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for T.MAN Pharmaceutical PCL and its competitors.
Is T.MAN Pharmaceutical PCL's Total Liabilities too high?
T.MAN Pharmaceutical PCL's current Total Liabilities is ฿1,635 Mil. Overall, T.MAN Pharmaceutical PCL has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does T.MAN Pharmaceutical PCL's Total Liabilities compare to ZTS and UTHR?
T.MAN Pharmaceutical PCL's Total Liabilities of ฿1,635 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for T.MAN Pharmaceutical PCL and its competitors. T.MAN Pharmaceutical PCL's current Total Liabilities is ฿1,635 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is T.MAN Pharmaceutical PCL stock overvalued right now?
T.MAN Pharmaceutical PCL (BKK:TMAN) has a current Total Liabilities of ฿1,635 Mil. The current Total Liabilities is ฿1,635 Mil. T.MAN Pharmaceutical PCL's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For T.MAN Pharmaceutical PCL (BKK:TMAN), the current Total Liabilities is ฿1,635 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

T.MAN Pharmaceutical PCL Business Description

Address Bangkhunthian Road, 69/1 Soi Bangkhunthian 14, Samaedum Subdistrict, Bangkhunthian District, Bangkok, THA, 10150
T.MAN Pharmaceutical PCL is engaged in purchasing, importing, manufacturing, and distributing original equipment and in manufacturing, distributing, and exporting modern medicines, traditional medicines, dietary supplements, and healthcare products for the healthcare industry. It offers products through brands such as T.Nutrition, T.Derma, Mommy&Me, TMT, Heaven Herb, and T.Pharmaceutical. The company's reportable segments are: Segment for manufactured products under own brand, which derives key revenue, Segment for manufactured products under third parties' brand, and Segment for trading products.
21GF Score

Get the complete analysis for BKK:TMAN

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿11.30
Price